EP300 and pulmonary arterial hypertension: To validate the anti-inflammatory effect of EP300 inhibition, we performed quantitative PCR analysis, which revealed significant downregulation of canonical pro-inflammatory transcripts, IL1B, IL6, and TNFA, all of which are known to be up-regulated in the lungs of PAH patients (Fig. 3G).